Stock RNT PRIVATE RENTED SECTOR S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Private Rented Sector S.A.

Equities

RNT

PLGURDR00013

Biotechnology & Medical Research

End-of-day quote Warsaw S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
6.5 PLN 0.00% Intraday chart for Private Rented Sector S.A. +4.84% +221.78%
Feb. 14 Private Rented Sector S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 Private Rented Sector S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 7.136 0.3964 2.511 3.832 2.392 15.59
Enterprise Value (EV) 1 8.712 2.521 5.033 6.705 2.375 15.56
P/E ratio -1.93 x -0.12 x -1.92 x -3.12 x - 193 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -2.49 x -0.76 x -4.36 x - - -
EV / FCF -3.74 x 1.36 x 22.6 x -97.3 x -0.15 x 3,020 x
FCF Yield -26.7% 73.6% 4.43% -1.03% -689% 0.03%
Price to Book -0.61 x -0.03 x -0.15 x -0.21 x - -212 x
Nbr of stocks (in thousands) 1,321 1,321 1,321 1,321 1,321 1,321
Reference price 2 5.400 0.3000 1.900 2.900 1.810 11.80
Announcement Date 6/1/18 5/31/19 7/24/20 5/31/21 5/31/23 5/31/23
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -3.503 -3.337 -1.155 - - -
EBIT 1 -3.506 -3.34 -1.158 -1.259 -1.54 0.1085
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -3.427 -3.815 -1.31 -1.228 7.997 0.08
Net income 1 -3.703 -3.392 -1.31 -1.228 7.913 0.0806
Net margin - - - - - -
EPS 2 -2.802 -2.567 -0.9911 -0.9292 - 0.0610
Free Cash Flow 1 -2.33 1.855 0.223 -0.0689 -16.37 0.005151
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - 6.39%
Dividend per Share - - - - - -
Announcement Date 6/1/18 5/31/19 7/24/20 5/31/21 5/31/23 5/31/23
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 1.58 2.12 2.52 2.87 - -
Net Cash position 1 - - - - 0.02 0.03
Leverage (Debt/EBITDA) -0.4498 x -0.6366 x -2.184 x - - -
Free Cash Flow 1 -2.33 1.85 0.22 -0.07 -16.4 0.01
ROE (net income / shareholders' equity) 34.7% 24.7% 7.94% 6.91% -85.6% -70.9%
ROA (Net income/ Total Assets) -113% -183% -724% -972% -1,003% 89.3%
Assets 1 3.285 1.854 0.1809 0.1264 -0.7885 0.0902
Book Value Per Share 2 -8.810 -11.90 -13.00 -13.90 - -0.0600
Cash Flow per Share 2 0.0300 0.0400 0.0200 0.0300 - 0.0300
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 6/1/18 5/31/19 7/24/20 5/31/21 5/31/23 5/31/23
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PRIVATE RENTED SECTOR S.A. Stock Private Rented Sector S.A.
+221.78% 2.12M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. RNT Stock
  4. Financials Private Rented Sector S.A.